Literature DB >> 4611526

Additional deficiency of psychosine galactosidase in globoid cell leukodystrophy: an implication to enzyme replacement therapy.

T Miyatake, K Suzuki.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4611526

Source DB:  PubMed          Journal:  Birth Defects Orig Artic Ser        ISSN: 0547-6844


× No keyword cloud information.
  4 in total

1.  Mechanism-based combination treatment dramatically increases therapeutic efficacy in murine globoid cell leukodystrophy.

Authors:  Jacqueline A Hawkins-Salsbury; Lauren Shea; Xuntian Jiang; Daniel A Hunter; A Miguel Guzman; Adarsh S Reddy; Elizabeth Y Qin; Yedda Li; Steven J Gray; Daniel S Ory; Mark S Sands
Journal:  J Neurosci       Date:  2015-04-22       Impact factor: 6.167

2.  Psychosine, the cytotoxic sphingolipid that accumulates in globoid cell leukodystrophy, alters membrane architecture.

Authors:  Jacqueline A Hawkins-Salsbury; Archana R Parameswar; Xuntian Jiang; Paul H Schlesinger; Ernesto Bongarzone; Daniel S Ory; Alexei V Demchenko; Mark S Sands
Journal:  J Lipid Res       Date:  2013-09-04       Impact factor: 5.922

3.  The morphologic similarities of human and canine globoid leukodystrophy. Thin section and freeze-fracture studies.

Authors:  E J Yunis; R E Lee
Journal:  Am J Pathol       Date:  1976-10       Impact factor: 4.307

4.  Lysosomal Re-acidification Prevents Lysosphingolipid-Induced Lysosomal Impairment and Cellular Toxicity.

Authors:  Christopher J Folts; Nicole Scott-Hewitt; Christoph Pröschel; Margot Mayer-Pröschel; Mark Noble
Journal:  PLoS Biol       Date:  2016-12-15       Impact factor: 8.029

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.